Information  X 
Enter a valid email address

Blancco Tech Grp PLC (BLTG)

  Print          Annual reports

Wednesday 09 October, 2019

Blancco Tech Grp PLC

Directors' Dealing

RNS Number : 3024P
Blancco Technology Group PLC
09 October 2019
 

BLANCCO TECHNOLOGY GROUP PLC

(the "Company")

Directors' Dealing

 

The Company has been notified that Matt Jones (Chief Executive Officer) has today purchased 10,000 ordinary shares of 2p each at a price of 126.5p. Adam Moloney (Chief Financial Officer) also purchased 10,000 ordinary shares of 2p each at a price of 126.5p.

 

Matt Jones and Adam Moloney now each hold 28,000 ordinary shares in the Company, representing 0.04% of the Company's issued share capital, respectively.

 

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail in respect of the transactions as described above.

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Matt Jones

2.

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Blancco Technology Group plc

b)

LEI:

2138008487QKMQTA5428

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Identification code:

Ordinary Shares of 2p each GB00B06GNN57

b)

Nature of the transaction:

Purchase

c)

Price(s) and volume(s):

    

Price(s)

Volume(s)

126.5p

10,000

d)

Aggregated information:

·    Aggregated volume:

·    Price:

Single transaction as in 4 c) above

10,000

  126.5p

e)

Date of the transaction:

2019-10-09

f)

Place of the transaction:

London Stock Exchange, AIM Market (XLON)

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Adam Moloney

2.

Reason for the notification

a)

Position/status:

Chief Financial Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Blancco Technology Group plc

b)

LEI:

2138008487QKMQTA5428

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Identification code:

Ordinary Shares of 2p each GB00B06GNN57

b)

Nature of the transaction:

Purchase

c)

Price(s) and volume(s):

    

Price(s)

Volume(s)

126.5p

10,000

d)

Aggregated information:

·    Aggregated volume:

·    Price:

Single transaction as in 4 c) above

10,000

126.5p

e)

Date of the transaction:

2019-10-09

f)

Place of the transaction:

London Stock Exchange, AIM Market (XLON)

 

Blancco Technology Group plc

Rob Woodward, Chair

Matt Jones, Chief Executive Officer

Adam Moloney, Chief Financial Officer

 

via Buchanan

Peel Hunt (Nominated Advisor & Broker)                                       

Edward Knight / Nick Prowting / Edward Allsopp

 

+44 (0) 20 7418 8900

Panmure Gordon (UK) Limited (Joint Broker)

Dominic Morley, Corporate Finance

Charles Leigh Pemberton, Corporate Broking                                                                         

 

+44 (0) 20 7886 2500

Buchanan Communications Limited

Chris Lane / Stephanie Watson / Charlotte Slater

[email protected]

 

+44 (0) 20 7466 5000

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHEANENELFNFEF

a d v e r t i s e m e n t